Clinical Trial Update: Mini-MARVEL - Mitochondrial Antioxidant Therapy in Ulcerative Colitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial Mini-MARVEL evaluating a mitochondrial antioxidant therapy for ulcerative colitis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Snippet

Sponsor: University of Edinburgh | Conditions: Ulcerative Colitis | Phase 2 | Status: WITHDRAWN